I was thinking about Herceptin in the ADJUVANT setting...OFF LABEL....NOT Herceptin in the Stage IV setting. In the adjuvant setting, there is more "caution" exerted, obviously, since there is no evidence of disease present to treat. In the mets setting, the risk envelope may be pushed more. And that is how drugs COME to the adjuvant setting...they are first tested on the metastatic population. If they work AND they are safe, then they get tested next in the adjuvant setting.
I think it is GREAT that you can continue to use Herceptin indefinitely.
|